ConductScience.org, home

Paper3290520

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients.

Corpier CL and 6 others. JAMA, 1988. Cited by 243 papers, by iCite.

Cite this record

ConductScience Library. Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. Papers, record 3290520. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3290520

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients.
PubMed
Journal
JAMA
PubMed
Year
1988
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
243
iCite
Relative citation ratio, by iCite
12
iCite
Revised in PubMed
2016-10-17
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Corpier CLC L
2Jones PHP H
3Suki WNW N
4Lederer EDE D
5Quinones MAM A
6Schmidt SWS W
7Young JBJ B

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acute Kidney InjuryMajor topic
HypercholesterolemiaMajor topic
LovastatinMajor topic
RhabdomyolysisMajor topic
Adult
Creatine Kinase
Heart Transplantation
Humans
Legionellosis
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.

PMIDTitleJournalYearIn PapersSource
39545952Towards streamlined product information: reporting of transporter-mediated drug interactions.Eur J Clin Pharmacol2025https://conductscience.org/library/papers/39545952PubMed
37688635Performance and mechanism of co-culture of Monascus purpureus, Lacticaseibacillus casei, and Saccharomyces cerevisiae to enhance lovastatin production and lipid-lowering effects.Bioprocess Biosyst Eng2023https://conductscience.org/library/papers/37688635PubMed
29389579A randomized, double-blind clinical study of the effects of Ankascin 568 plus on blood lipid regulation.J Food Drug Anal2018https://conductscience.org/library/papers/29389579PubMed
29204172Protective effects of coenzyme Q10 and L-carnitine against statin-induced pancreatic mitochondrial toxicity in rats.Res Pharm Sci2017https://conductscience.org/library/papers/29204172PubMed
24700094Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.World J Surg2014https://conductscience.org/library/papers/24700094PubMed
19159124Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.Am J Cardiovasc Drugs2008https://conductscience.org/library/papers/19159124PubMed
16722833
Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.
Br J Clin Pharmacol2006https://conductscience.org/library/papers/16722833PubMed
15139786Management of hyperlipidaemia associated with heart transplantation.Drugs2004https://conductscience.org/library/papers/15139786PubMed
14531725Clinical pharmacokinetics of atorvastatin.Clin Pharmacokinet2003https://conductscience.org/library/papers/14531725PubMed
12495360Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?Drug Saf2003https://conductscience.org/library/papers/12495360PubMed
12036392Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.Clin Pharmacokinet2002https://conductscience.org/library/papers/12036392PubMed
11599634How well tolerated are lipid-lowering drugs?Drugs Aging2001https://conductscience.org/library/papers/11599634PubMed
11259986The effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjects.Br J Clin Pharmacol2001https://conductscience.org/library/papers/11259986PubMed
11122720Does differing metabolism by cytochrome p450 have clinical importance?Curr Atheroscler Rep2000https://conductscience.org/library/papers/11122720PubMed
10668858Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.Clin Pharmacokinet2000https://conductscience.org/library/papers/10668858PubMed
9929751Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia.Clin Cardiol1999https://conductscience.org/library/papers/9929751PubMed
9515185Clinical pharmacokinetics of fibric acid derivatives (fibrates).Clin Pharmacokinet1998https://conductscience.org/library/papers/9515185PubMed
9160173Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.Clin Pharmacokinet1997https://conductscience.org/library/papers/9160173PubMed
9118815Choosing the right lipid-regulating agent. A guide to selection.Drugs1996https://conductscience.org/library/papers/9118815PubMed
8521762Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.Drugs1995https://conductscience.org/library/papers/8521762PubMed

See all 34 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3290520

GET https://conductscience.org/api/papers/v1/3290520/cited_by?page=2